# A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)

> **NCT07012629** · PHASE3 · RECRUITING · sponsor: **Aarhus University Hospital** · enrollment: 1652 (estimated)

## Conditions studied

- Covert Brain Infarction

## Interventions

- **DRUG:** acetylsalicyclic acid (ASA)
- **DRUG:** Clopidogrel
- **DRUG:** Rosuvastatin
- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT07012629
- **Lead sponsor:** Aarhus University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-11-26
- **Primary completion:** 2031-09-30
- **Final completion:** 2040-01-01
- **Target enrollment:** 1652 (ESTIMATED)
- **Last updated:** 2025-12-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07012629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07012629, "A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT07012629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*